Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics, GeneKor Expand Distribution Agreement

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its distribution agreement with GeneKor Medical has been expanded to include Romania and Turkey.

GeneKor now has the exclusive sales and marketing rights to Rosetta Genomics' microRNA-based cancer testing services in Romania, and non-exclusive rights in Turkey. The companies originally inked a distribution deal covering Greece in 2010.

Financial and other terms of today's deal were not disclosed.

GeneKor is a molecular diagnostic service provider headquartered in Athens, Greece.

"This extension to our agreement with GeneKor will enhance patient access to our microRNA-based testing services in Turkey and Romania, and will potentially result in more personalized treatment approaches for many patients," E. Robert Wassman, chief medical officer of Rosetta Genomics, said in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.